abbv-383
Showing 1 - 3 of 3
Relapsed/Refractory Multiple Myeloma Trial in Japan (ABBV-383)
Recruiting
- Relapsed/Refractory Multiple Myeloma
- ABBV-383
-
Kashiwa-shi, Chiba, Japan
- +5 more
Jan 25, 2023
Multiple Myeloma Trial in Worldwide (ABBV-383)
Not yet recruiting
- Multiple Myeloma
- ABBV-383
-
Phoenix, Arizona
- +12 more
Dec 6, 2022
Relapsed/Refractory Multiple Myeloma Trial in Worldwide (ABBV-383, Dexamethasone, Lenalidomide)
Not yet recruiting
- Relapsed/Refractory Multiple Myeloma
- ABBV-383
- +5 more
-
Little Rock, Arkansas
- +45 more
Jul 8, 2022